Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
0.8097
-0.1493 (-15.57%)
May 15, 2026, 1:07 PM EDT - Market open
Jasper Therapeutics Market Cap
Jasper Therapeutics has a market cap or net worth of $22.67 million as of May 15, 2026. Its market cap has decreased by -71.11% in one year.
Market Cap
22.67M
Enterprise Value
-608.05K
1-Year Change
-71.11%
Ranking
Category
Stock Price
$0.81
Market Cap Chart
Since May 17, 2021, Jasper Therapeutics's market cap has decreased from $3.76B to $22.67M, a decrease of -99.40%. That is a compound annual growth rate of -64.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 23.23M | -15.50% |
| Dec 31, 2025 | 27.49M | -91.18% |
| Dec 31, 2024 | 311.82M | 257.84% |
| Dec 29, 2023 | 87.14M | 392.23% |
| Dec 30, 2022 | 17.70M | -99.38% |
| Dec 31, 2021 | 2.85B | -24.10% |
| May 17, 2021 | 3.76B | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dyadic International | 25.54M |
| Werewolf Therapeutics | 25.39M |
| Serina Therapeutics | 25.25M |
| Vistagen Therapeutics | 24.96M |
| Marker Therapeutics | 24.15M |
| Outlook Therapeutics | 23.18M |
| Celularity | 23.08M |
| GridAI Technologies | 22.94M |